Resources

Publications

05/08/2025
- Oncology
Molecular Landscape of Patients (Pts) With Metastatic Breast Cancer (mBC) Who Progressed on Second-Line (2L) Selective Estrogen Receptor Degraders (SERDs)
ESMO BC 2025
05/02/2025
- Oncology
A Phase I, Open-Label, Multicentre, First-in-Human Study to Evaluate Safety, Pharmacokinetics and Efficacy of AMG 404, a PD-1 Inhibitor, in Patients With Advanced Solid Tumours
BMJ Open
05/01/2025
- Oncology
Baseline Biomarker Analyses of Patients With Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer (mCRC) From the Phase 3 CodeBreaK 300 Study
AACR 2025
05/01/2025
- Oncology
Analysis of multimodal real world data from 1,248 breast cancer patients reveals distinct, novel consensus molecular segments associated with CDK4/6 inhibitor resistance
AACR 2025
05/01/2025
- Oncology
Enhancing TCR-T With a Fas-Based Switch Receptor Boosts T Cell Engraftment, Persistence, and Anti-Tumor Activity in Models of Hard-To-Treat PRAME Solid Tumor Indications
AACR 2025
05/01/2025
- Oncology
CLSP-1025, a First-in-Class Precision T Cell Engager for the Treatment of p53 Mutant Cancers
AACR 2025
04/25/2025
- Oncology
Analytical Validation of Next-Generation Sequencing-Based Comprehensive Liquid Biopsy Assay for Therapy Selection
The Journal of Molecular Diagnostics
04/10/2025
- Oncology
Benchmarking of Germline Copy Number Variant Callers From Whole Genome Sequencing Data for Clinical Applications
Bioinformatics Advances
03/28/2025
- Oncology
Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic Essentiality
Clinical Cancer Research
03/25/2025
- Oncology
Identification of Predictive Biomarkers of Response to ADCs by HTS of Highly Molecularly Characterized Panels of Patient-Derived Organoids (PDOs)
AACR 2025

5 6 7